Table 2 Ultrasound scan, non-invasive fibrosis tests and laboratory investigations

Ultrasound scan

 Multiple lesions/Single lesion/No lesion

175 (67.3)/ 60 (23) / 25 (9.6)

Fibroscan (n = 169)

 Fibroscan (kPa): median (range)

75 (4–75)

Fibrosis 4 (n = 231)

 median (range)

4.6 (0.37–69.9)

 > 1.45

202 (87.5)

 > 3.25

143 (61.9)

Aspartate transferase to platelet ratio (n = 232)

 Median (range)

2.2 (0.1–102.7)

 ≥ 1.5

152 (65.5)

 > 2

121 (52.2)

Laboratory investigations

 Hepatitis B surface antigen

  • Positive

170 (65.4)

  • Missing

4(1.5)

 Human immunodeficiency virus

  • Positive

11(5.2)

 Alpha-fetoprotein (ng/ml)

3263 (1.07–116,000)

 International normalized ratio

1.3(0.9–4.9)

 Haemoglobin (g/dl)

11.3 (4.8–18.4)

 White Cell Count (× 10⁹/l)

7.8 (1.8–34.8)

 Red cell count (× 10¹²/l)

4.1 (0.9–7.7)

 Platelet count(× 10⁹/l)

222(33–941)

 Sodium(mmol/l)

139(121–151)

 Potassium (mmol/l)

4.3 (3.36–10.6)

 Creatinine (umol/l)

67(13–949)

 Glucose (mmol/l)

4.5(0.9–13.4)

 Aspartate Transferase (U/L)

194(18–7886)

 Alanine Transferase ( U/L)

61(5–937)

 Total Bilirubin (umol/l)

32(0–646)

 Gamma glutamyl Transferase ( U/L)

315(11–3677)

 Alkaline phosphatase (U/L)

282(28–4063)

 Albumin (g/L)

33(10–52)